Most patients do not experience any adverse side effects
Whilst blood in stool is not a recognised adverse reaction in the MHRA-approved Summary of Product Characteristics, patients may experience gastrointestinal side effectssuch as constipationthat can indirectly contribute to rectal bleeding
PubMed record Allen J, Bradley RD
136,169,170 With the accumulation of more clinical data and the development of new drugs, these treatment options are expected to provide more effective and comprehensive treatment choices for diabetes patients
dose adjustments needed Comparison: Retatrutide vs Wegovy vs Mounjaro Side Effects Side-by-Side Comparison Key Differences Retatrutide unique: Dysesthesia (20.9%) NOT seen with others Highest efficacy (28.328.7% weight loss) Higher discontinuation in osteoarthritis population (18.2%), more comparable in general obesity (11.3%) Semaglutide unique: Best tolerability (6.9% discontinuation) More constipation (24%) Lower efficacy (14.9% weight loss) Tirzepatide middle ground: Moderate tolerability (6.2% discontinuation) Strong efficacy (22.5% weight loss) Similar GI profile to both Bottom line: All three have similar GI side effects
Peptides including glutathione, kisspeptin, melatonin derivatives, BPC-157, and carnosine exhibit antioxidant, anti-inflammatory, and tissue-repair properties that can assist oocyte and sperm quality and enhance reproductive indicators